ÂÜÀòÂÒÂ×

Sofia Paul is an accomplished professional in the field of biostatistics with extensive experience in leadership roles across prominent pharmaceutical companies. Currently serving as Executive Director at Syros Pharmaceuticals since December 2021, Sofia previously held the position of Senior Director of Biostatistics at GSK from July 2018 to December 2021. Prior to that, an extensive tenure at Novartis spanned from January 2006 to July 2018, during which Sofia progressed from Director Biostatistics to Senior Director Biostatistics. Earlier in a career at Eli Lilly and Company from 1996 to 2006, Sofia worked as a Principal Research Scientist. Academic credentials include a PhD in Statistics obtained from the University of Florida, completed in 1996.